Advertisement

Topics

Biotheranostics & Syapse Collaborate to Integrate Genomics-Based Molecular Diagnostics for Cancer into the Syapse Precision Medicine Platform

05:30 EDT 23 Sep 2016 | Biotech-Finances

Thursday, September 22nd 2016 at 5:18pm UTC Breast Cancer Index & CancerTYPE ID Tests Provide Patient-Specific Information to Aid in Treatment Decisions with the Goal of Improving Outcomes SAN DIEGO & PALO ALTO, Calif.–(BUSINESS WIRE)– Biotheranostics, Inc., a pioneer in molecular diagnostics for cancer, and Syapse, the leader in precision medicine software, announce plans to …

Cet article Biotheranostics & Syapse Collaborate to Integrate Genomics-Based
Molecular Diagnostics for Cancer into the Syapse Precision Medicine
Platform
est apparu en premier sur EEI-BIOTECHFINANCES.

Original Article: Biotheranostics & Syapse Collaborate to Integrate Genomics-Based Molecular Diagnostics for Cancer into the Syapse Precision Medicine Platform

NEXT ARTICLE

More From BioPortfolio on "Biotheranostics & Syapse Collaborate to Integrate Genomics-Based Molecular Diagnostics for Cancer into the Syapse Precision Medicine Platform"

Quick Search
Advertisement
 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...